beremagene geperpavec (Pending FDA Approval)

Brand and Other Names:Vyjuvek
  • Print
Sections

Dosing & Uses

Epidermolysis Bullosa

Topical gene therapy pending FDA approval

Next:

Pharmacology

Mechanism of Action

Recombinant herpes simplex virus type 1 (HSV-1) vector expressing the COL7A1 gene, which encodes type VII collagen

In recessive dystrophic epidermolysis bullosa, a flawed COL7A1 gene results in loss of type VII collagen, an important structural skin protein

Previous
Next:

Images

Pricing & Images are not currently available for this monograph.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.